| Adjuvant | supportive therapy applied after initial main treatment. |
| Akt | (protein kinase B), an enzyme that plays a role in cell metabolism, especially the insulin pathway. |
| AMPK | (5′ adenosine monophosphate-activated protein kinase), an enzyme involved in cell metabolism. |
| Analogue | a compound similar in structure to another. |
| Angiogenesis | formation of new blood vessels. |
| Apoptosis | death of cells by a pre-programmed genetic mechanism. |
| Autophagy | a mode of cell death, removing damaged proteins, organelles and pathogens. |
| Beta (β)-catenin | protein that plays a role in cell signaling and cell-cell adhesion. |
| Bioavailability | the proportion of a substance that can be absorbed by the body. |
| Biomarker | a molecule from which a biological process can be identified. |
| BMI | (body-mass index, the body weight in kg divided by the square of the body height in meters), a measure of obesity. |
| Cachexia | late-stage weakness and wasting of the body due to severe illness. |
| CA9 | (carbonic anhydrase-9), an enzyme involved in controlling the body’s acidity. |
| Case-control study | a retrospective study comparing the effect of a given measurable factor on a group of people, compared with a control (non-exposed) group. |
| Carcinogenesis | formation of cancer. |
| Caspase-3 | an enzyme involved in apoptosis. |
| Clinical trial | testing of a drug on humans prior to official approval, beginning with basic toxicity (phase I) and leading to more detailed evaluation on increasing numbers of patients (phases II–IV). |
| Cohort study | a longitudinal (time-course) study testing the effect of a certain treatment on a group of people, normally in comparison with a control (untreated) group. |
| Cytokine | signaling molecule (protein) involved in cell signaling, common in the immune system. |
| Desmoplasia | dense fibrous tissue. |
| EGF | (epidermal growth factor), a protein involved in the growth, proliferation and differentiation of cells. |
| EGFR | (epidermal growth factor receptor), a protein acted upon by epidermal growth factor. |
| EMT | (epithelial-mesenchymal transition), an early event/morphological change in cancer cells becoming invasive. |
| Epigenetic | regulation of gene expression levels. |
| Flavonoid | groups of chemicals, pigments, found in plants that have anti-oxidative and anti-inflammatory properties. |
| 5-FU | (5-fluorouracil), a common anti-cancer drug (‘chemotherapy’) often used in combination with other medications. |
| FOLFIRINOX | (folinic acid, fluorouracil, irinotecan and oxaliplatin), a combination chemotherapy drug. |
| GPCR | (G protein-coupled receptor), a protein found on the cell membrane that interacts with incoming signaling molecules. |
| Hedgehog | a signaling mechanism operating in cells, especially during development, and tumorigenesis; sonic hedgehog is a main protein. |
| Hydrogel | cross-linked polymer gel that can absorb and retain water. |
| Hyperplasia | increase in the number of cells within an organ or tissue, forming a barrier. |
| IGF | (insulin-like growth factor), a protein involved in the growth, proliferation and differentiation of cells; shares the same receptor with insulin. |
| Intraperitoneal | an injection into the abdominal cavity of the body. |
| Isoform | a protein with the same function as another but differing slightly in structure. |
| Isomers | a molecule with the same formula but different structure. |
| KPC | a genetically modified mouse model of pancreatic cancer. |
| KRAS | a gene that, when mutated, can cause cells to become cancerous. |
| Macrophage | a type of cell found in the immune system, detects and destroys harmful microorganisms. |
| MAPK | (mitogen associated protein kinase), an enzyme that has a central involvement in the cancer process. |
| Meta-analysis | quantitative study that uses the results of multiple previous analyses to achieve a consensus opinion. |
| Microbiome | microorganisms, especially bacteria, that reside in parts of the body e.g., the gut. |
| Neo-adjuvant | initial therapy applied before the main treatment, e.g., chemotherapy or radiation therapy. |
| Neoplasm | new and abnormal growth of tissue, commonly leading to cancer. |
| NF-kB | (nuclear factor kappa-light-chain-enhancer of activated B cells), a protein involved in gene expression and patho/physiological regulation. |
| Notch | a protein involved in cellular signaling, especially during development, and cancer. |
| Orthotopic | something occurring in its normal location. |
| PanIN | (pancreatic intraepithelial neoplasia), a pathological indicator of pancreatic cancer and its grade. |
| PDAC | (pancreatic ductal adenocarcinoma), the most common type of pancreatic cancer. |
| PDX | (patient derived xenograft), human cancer tissue implanted and surviving in an animal model. |
| PI3K | (phosphoinositide 3-kinase), an enzyme involved in cell signaling. |
| Polyphenol | a type of plant-derived chemical with health benefits. |
| Rho-kinase | a protein/enzyme involved in cell signaling, often as an intermediary. |
| STAT3 | (signal transducer and activator of transcription 3), a protein involved in cell signaling and gene regulation. |
| T-cell | a type of lymphocyte (white blood cell) that is a central part of the immune system. |
| TGFβ | (transforming growth factor beta), a primary signaling protein involved in cellular mechanisms. |
| TRAIL | (tumor necrosis factor-related apoptosis-inducing ligand), a protein that promotes programmed cell death. |
| Transgenic | an organism that contains genetic information from another organism, often used as cancer models. |
| Wnt | (Wingless and Int-1), a signaling mechanism operating in cells, especially during development and tumorigenesis; incorporates a variety of Wnt proteins. |
| Xenograft | a tissue from one species, grafted experimentally to another (often human to mouse). |